FDA — authorised 13 June 2018
- Marketing authorisation holder: MDGH
- Status: approved
🇺🇸 Moxidectin in United States
FDA authorised Moxidectin on 13 June 2018
Marketing authorisations
FDA — authorised 13 June 2018
- Application: NDA210867
- Marketing authorisation holder: MDGH
- Local brand name: MOXIDECTIN
- Indication: TABLET — ORAL
- Status: approved
Moxidectin in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Infectious Disease approved in United States
Frequently asked questions
Is Moxidectin approved in United States?
Yes. FDA authorised it on 13 June 2018; FDA authorised it on 13 June 2018.
Who is the marketing authorisation holder for Moxidectin in United States?
MDGH holds the US marketing authorisation.